Berdowska Izabela, Matusiewicz Małgorzata, Krzystek-Korpacka Małgorzata
Department of Medical Biochemistry, Wroclaw Medical University, Chałubińskiego 10, 50-368 Wroclaw, Poland.
Antioxidants (Basel). 2022 Mar 9;11(3):524. doi: 10.3390/antiox11030524.
Parkinson's disease (PD)-a neurodegenerative disorder (NDD) characterized by progressive destruction of dopaminergic neurons within the substantia nigra of the brain-is associated with the formation of Lewy bodies containing mainly α-synuclein. HDL-related proteins such as paraoxonase 1 and apolipoproteins A1, E, D, and J are implicated in NDDs, including PD. Apolipoprotein J (ApoJ, clusterin) is a ubiquitous, multifunctional protein; besides its engagement in lipid transport, it modulates a variety of other processes such as immune system functionality and cellular death signaling. Furthermore, being an extracellular chaperone, ApoJ interacts with proteins associated with NDD pathogenesis (amyloid β, tau, and α-synuclein), thus modulating their properties. In this review, the association of clusterin with PD is delineated, with respect to its putative involvement in the pathological mechanism and its application in PD prognosis/diagnosis.
帕金森病(PD)是一种神经退行性疾病(NDD),其特征是大脑黑质内的多巴胺能神经元进行性破坏,与主要包含α-突触核蛋白的路易小体形成有关。与高密度脂蛋白(HDL)相关的蛋白质,如对氧磷酶1和载脂蛋白A1、E、D和J,与包括PD在内的神经退行性疾病有关。载脂蛋白J(ApoJ,clusterin)是一种普遍存在的多功能蛋白质;除了参与脂质运输外,它还调节多种其他过程,如免疫系统功能和细胞死亡信号传导。此外,作为一种细胞外伴侣蛋白,ApoJ与神经退行性疾病发病机制相关的蛋白质(淀粉样β蛋白、tau蛋白和α-突触核蛋白)相互作用,从而调节它们的特性。在这篇综述中,阐述了clusterin与PD的关联,涉及其在病理机制中的假定作用及其在PD预后/诊断中的应用。